Emerging strategies for the treatment of pulmonary tuberculosis: promise and limitations?
Wing-Wai YEW; Won-Jung KOH.
The Korean Journal of Internal Medicine
; : 15-29, 2016.
Artículo en Inglés | WPRIM | ID: wpr-149379
Documentos relacionados
Clp-targeting BacPROTACs impair mycobacterial proteostasis and survival.
An end-to-end heterogeneous graph attention network for Mycobacterium tuberculosis drug-resistance prediction.
Clinical research progress of novel antituberculosis drugs on multidrug-resistant tuberculosis.
Challenging the gold standard: the limitations of molecular assays for detection of <i>Mycobacterium tuberculosis</i> heteroresistance.
Chemical disarming of isoniazid resistance in <i>Mycobacterium tuberculosis</i>.
Key challenges in TB drug discovery: A perspective.
Resistance-Conferring Mutations on Whole-Genome Sequencing of Fluoroquinolone-resistant and -Susceptible Mycobacterium tuberculosis Isolates: A Proposed Threshold for Identifying Resistance.
Rapid, antibiotic incubation-free determination of tuberculosis drug resistance using machine learning and Raman spectroscopy.
Heteroresistance in tuberculosis: are we missing drug-resistant bacteria hiding in plain sight?
Genome-wide gene expression tuning reveals diverse vulnerabilities of M. tuberculosis.